Off-Label Coverage of High-Cost Drugs by Independent Charity Patient Assistance Programs
J Gen Intern Med
.
2021 Feb;36(2):555-556.
doi: 10.1007/s11606-020-05682-9.
Epub 2020 Feb 24.
Authors
So-Yeon Kang
1
,
Mariana P Socal
2
,
Ge Bai
2
3
,
Gerard F Anderson
2
Affiliations
1
Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA. skang57@jhu.edu.
2
Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
3
Johns Hopkins Carey Business School, Bernstein-Offit Building 353, 1717 Massachusetts Ave NW, Washington, DC, 20036, USA.
PMID:
32096083
PMCID:
PMC7878656
DOI:
10.1007/s11606-020-05682-9
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Charities
Drug Costs
Humans
Insurance Coverage
Off-Label Use*
Pharmaceutical Preparations*
Substances
Pharmaceutical Preparations